PL2341056T3 - Sposób krystalizacji erytromycyny - Google Patents

Sposób krystalizacji erytromycyny

Info

Publication number: PL2341056T3
Authority: PL; Poland
Prior art keywords: erythromycin; crystallizing method; crystallizing
Prior art date: 2008-10-29

Application number

PL09822979T

Other languages

English (en)

Inventor

Xiaoping Ma

Luning Song

Original Assignee

Sunshine Lake Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-10-29

Filing date

2009-10-29

Publication date

2013-10-31

2009-10-29 Application filed by Sunshine Lake Pharma Co Ltd filed Critical Sunshine Lake Pharma Co Ltd

2013-10-31 Publication of PL2341056T3 publication Critical patent/PL2341056T3/pl

Links

ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title 2
229960003276 erythromycin Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Oncology (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Saccharide Compounds (AREA)

PL09822979T 2008-10-29 2009-10-29 Sposób krystalizacji erytromycyny PL2341056T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
CN2008102253108A CN101724000B (zh)	2008-10-29	2008-10-29	一种红霉素的结晶方法
PCT/CN2009/001204 WO2010048786A1 (zh)	2008-10-29	2009-10-29	一种红霉素的结晶方法
EP09822979.2A EP2341056B1 (en)	2008-10-29	2009-10-29	Crystallizing method of erythromycin

Publications (1)

Publication Number	Publication Date
PL2341056T3 true PL2341056T3 (pl)	2013-10-31

Family

ID=42128202

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL09822979T PL2341056T3 (pl)	2008-10-29	2009-10-29	Sposób krystalizacji erytromycyny

Country Status (10)

Country	Link
US (1)	US8436154B2 (pl)
EP (1)	EP2341056B1 (pl)
JP (1)	JP5596695B2 (pl)
CN (1)	CN101724000B (pl)
AU (1)	AU2009310267B2 (pl)
ES (1)	ES2423795T3 (pl)
HR (1)	HRP20130516T1 (pl)
PL (1)	PL2341056T3 (pl)
SI (1)	SI2341056T1 (pl)
WO (1)	WO2010048786A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102199179B (zh) *	2011-03-14	2013-09-11	金泳霖	一种净化并回收利用发酵法生产红霉素料液的方法
CN102942607A (zh) *	2012-11-28	2013-02-27	宁夏启元药业有限公司	一种复合溶剂结晶红霉素的方法
CN105622690A (zh) *	2016-03-25	2016-06-01	伊犁川宁生物技术有限公司	一种高纯度红霉素a的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2864817A (en) *	1955-09-01	1958-12-16	Lilly Co Eli	Process for crystallization of erythromycin
US4751220A (en) *	1986-12-19	1988-06-14	E. R. Squibb & Sons, Inc.	Crystalline salts of [3S(Z)]-2[[[1-(2-amino-4-thiazolyl)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl]amino]-2-oxoethylidene]-amino]oxy]acetic acid
RO99792B1 (ro) *	1987-12-28	1990-06-29	Institutul De Cercetari Chimico-Farmaceutice	Procedeu de cristalizare a eritromicinei
RO103274A2 (en) *	1988-12-28	1991-12-09	Inst De Cercetari Chimico Farm	Recovery method of erythromycin from mother-waters
JP2007204490A (ja) *	1995-08-03	2007-08-16	Chugai Pharmaceut Co Ltd	エリスロマイシン誘導体の製造方法
EP1490382A4 (en) *	2002-04-03	2007-09-12	Hanmi Pharm Ind Co Ltd	PROCESS FOR PREPARING AZITHROMYXIN AND HYDRATE CRYSTALLINE 9-DEOXO-9A-HOMOERYTHROMYCIN
CN1219788C (zh)	2003-03-27	2005-09-21	华东理工大学	红霉素盐制备红霉素的动态控制结晶方法

2008
- 2008-10-29 CN CN2008102253108A patent/CN101724000B/zh active Active
2009
- 2009-10-29 AU AU2009310267A patent/AU2009310267B2/en active Active
- 2009-10-29 HR HRP20130516AT patent/HRP20130516T1/hr unknown
- 2009-10-29 US US13/063,933 patent/US8436154B2/en active Active
- 2009-10-29 EP EP09822979.2A patent/EP2341056B1/en active Active
- 2009-10-29 JP JP2011533513A patent/JP5596695B2/ja active Active
- 2009-10-29 WO PCT/CN2009/001204 patent/WO2010048786A1/zh not_active Ceased
- 2009-10-29 ES ES09822979T patent/ES2423795T3/es active Active
- 2009-10-29 PL PL09822979T patent/PL2341056T3/pl unknown
- 2009-10-29 SI SI200930687T patent/SI2341056T1/sl unknown

Also Published As

Publication number	Publication date
EP2341056A1 (en)	2011-07-06
JP2012506877A (ja)	2012-03-22
EP2341056B1 (en)	2013-05-29
EP2341056A4 (en)	2012-03-14
HK1153202A1 (en)	2012-03-23
CN101724000B (zh)	2012-05-30
WO2010048786A1 (zh)	2010-05-06
SI2341056T1 (sl)	2013-09-30
US8436154B2 (en)	2013-05-07
JP5596695B2 (ja)	2014-09-24
HRP20130516T1 (en)	2013-07-31
AU2009310267B2 (en)	2013-06-20
CN101724000A (zh)	2010-06-09
ES2423795T3 (es)	2013-09-24
US20110172402A1 (en)	2011-07-14
AU2009310267A1 (en)	2010-05-06

Similar Documents

Publication	Publication Date	Title
ZA201103032B (en)	2012-02-29	Method of synthesizing macrolide compounds
IL238338A0 (en)	2015-06-30	Processes for preparing sglt2 inhibitors
GB0810051D0 (en)	2008-07-09	Method of diagnosis
PL2376507T3 (pl)	2013-10-31	Sposób otrzymywania hydroksymetylofosfonianów
GB0711697D0 (en)	2007-07-25	Method of manufacture
IL243248A0 (en)	2016-02-29	Purification method
GB0702402D0 (en)	2007-03-21	Method of creating crystalline substances
EP2233548A4 (en)	2014-04-09	PROCESS FOR PRODUCING FERROCOKE
EP2455060A4 (en)	2015-09-30	METHOD FOR PRODUCING A VESICLE COMPOSITION
GB0915664D0 (en)	2009-10-07	Reaction method
IL217192A0 (en)	2012-02-29	Biorefinery method
GB0702857D0 (en)	2007-03-28	Improved sucralose production method
EP2197859A4 (en)	2011-11-30	PROCESS FOR PRODUCING BENZOXAZINONE-BASED COMPOUND
PL2341056T3 (pl)	2013-10-31	Sposób krystalizacji erytromycyny
GB2459738B (en)	2013-03-06	Method of purification
EP2211616A4 (en)	2011-07-13	PROCESS FOR PREPARING IMIDAZOAZEPINONE COMPOUNDS
EP2017254A4 (en)	2010-05-19	CRYSTALLIZATION PROCESS
IL212902A0 (en)	2011-07-31	Method of preparing deoxyribofuranose compounds
IL205857A0 (en)	2010-11-30	Processes for preparation of crystalline tigecyclline form ii
PL382168A1 (pl)	2007-10-01	Sposób wytwarzania S-(-)- 8-metoksy -2 tetralolu
GB0805997D0 (en)	2008-05-07	Method for the production of sucralose
GB0803197D0 (en)	2008-04-02	Method for the production of sucralose
TWI340474B (en)	2011-04-11	Method of forming semiconductor structure
GB0805344D0 (en)	2008-04-30	isolation method
GB0821365D0 (en)	2008-12-31	Method of manufacture